@article{1c4a42fbf2f64ee591c1f53de48251f0,
title = "High Circulating Triglycerides Are Most Commonly a Marker of Ectopic Fat Accumulation: Connecting the Clues to Advance Lifestyle Interventions",
keywords = "adiposity, alanine aminotransferase, cardiovascular diseases, glycated hemoglobin A, lifestyle factors, lipoproteins, LDL, triglycerides",
author = "Naveed Sattar and McGuire, {Darren K.} and Gill, {Jason M.R.}",
note = "Funding Information: The work in this study is supported by the British Heart Foundation Center of Research Excellence (Grant RE/18/6/34217). Funding Information: Dr Sattar reports personal fees from Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Merck Sharp and Dohme, Novartis, Novo Nordisk, Pfizer, and Sanofi; and grant funding paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics outside the submitted work. Dr McGuire reports honoraria for clinical trial leadership from Boehringer Ingelheim, Sanofi, Merck and Co., Pfizer, AstraZeneca, Novo Nordisk, Esperion, Lilly USA, Lexicon, and CSL Behring; as well as honoraria for consultancy from Lilly USA, Boehringer Ingelheim, Merck and Co, Novo Nordisk, Applied Therapeutics, Metavant, Sanofi, Afimmune, CSL Behring, and Bayer. Dr Gill reports no conflicts.",
year = "2022",
month = jul,
day = "12",
doi = "10.1161/CIRCULATIONAHA.122.060411",
language = "English (US)",
volume = "146",
pages = "77--79",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}